Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Gamma-Aminobutyric Acid,Alprazolam
Therapeutic Area : Endocrinology
Study Phase : Phase I/ Phase II
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : The Swedish Medical Products Agency has approved an amendment to ReGenerate-1 to investigate Remygen®'s preventive effects on hypoglycaemia (severely reduced blood sugar level) in individuals with long-term type 1 diabetes.
Brand Name : Remygen
Molecule Type : Small molecule
Upfront Cash : Not Applicable
August 24, 2020
Lead Product(s) : Gamma-Aminobutyric Acid,Alprazolam
Therapeutic Area : Endocrinology
Highest Development Status : Phase I/ Phase II
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Lead Product(s) : Alprazolam
Therapeutic Area : Neurology
Study Phase : Phase III
Sponsor : UCB Pharma S.A
Deal Size : $270.0 million
Deal Type : Acquisition
UCB Acquires Engage Therapeutics for Staccato® Alprazolam
Details : With is acquisition, UCB will have world-wide rights to Staccato[®] Alprazolam and would perform further clinical development, submission, launch and commercialization of Staccato[®] Alprazolam.
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : $125.0 million
June 05, 2020
Lead Product(s) : Alprazolam
Therapeutic Area : Neurology
Highest Development Status : Phase III
Sponsor : UCB Pharma S.A
Deal Size : $270.0 million
Deal Type : Acquisition
Lead Product(s) : Alprazolam
Therapeutic Area : Neurology
Study Phase : Phase II
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : Staccato alprazolam has demonstrated the ability to rapidly terminate seizures in patients with epilepsy in two minutes or less and prevent recurrence of seizure within two hours.
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : Not Applicable
March 12, 2020
Lead Product(s) : Alprazolam
Therapeutic Area : Neurology
Highest Development Status : Phase II
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?